Hesai (HSAI) Q2 2026 Earnings Call Transcript

Hesai reported Q2 2026 total net revenues of RMB 861M (USD 127M), up 22% YoY, alongside GAAP net income of RMB 71M (USD 10M), up 60% YoY, and 628,275 lidar units (+78.4% YoY). Robotics lidar shipments nearly tripled (142,371 units, +193.4% YoY) and the company raised full-year 2026 SGI revenue guidance to RMB 200M–300M (from RMB 100M), driven by faster actuation commercialization, while reiterating full-year 2026 lidar shipments of 3.0M–3.5M units. Management also guided Q3 2026 revenue to RMB 1.1B–1.15B with lidar shipments of 800,000–850,000 units, expecting revenue from outside ADAS to reach at least ~half of total in Q3.

Analysis

The key read-through is not “better lidar demand,” but a rising content-per-platform story: more sensors per vehicle, more premium mix, and a second engine that could eventually change the valuation multiple if it proves repeatable. That matters because unit growth alone is not enough to sustain rerating in a market that already expects China ADAS penetration to rise; the more durable upside is that HSAI is moving from a single-product component supplier to a safety-critical systems vendor with higher switching costs and less pure price elasticity.

Near term, the core business still funds the expansion, which reduces balance-sheet risk and gives the company room to outspend smaller peers in a pricing war. The second-order effect is that weaker lidar vendors likely get forced into discounting or niche positioning, while OEMs like LI, VWAGY and XIACY may see better ADAS differentiation but also more BOM pressure as multi-lidar configs spread. For customers, the economics look increasingly like a safety feature arms race, not an optional add-on; that tends to favor the lowest-cost credible incumbent with scale manufacturing and automotive validation.

The bigger catalyst path is 1-3 months of evidence, not the long-dated TAM narrative: Q3 mix, non-ADAS revenue crossing meaningful scale, and whether SGI can stay on a credible path to 2027 breakeven. The contrarian risk is that the market may be extrapolating prototype wins and affiliated demand into a durable software/services stack too early; Kosmo and actuation are still small and concentration risk around Sharpa is real. What would falsify the thesis is any sign of margin erosion below the high-30s, delayed revenue conversion in SGI, or a slip in the 2027 regulatory timeline that slows multi-lidar adoption.

Key Decisions for Investors

• Buy HSAI only on post-print weakness over the next 1-2 sessions; the better entry is a retrace toward the low end of the gap rather than chasing momentum. Base case is a 1-3 month rerating into Q3 mix inflection, with downside if gross margin slips below ~38%.
• Use Jan-2027 call spreads on HSAI rather than outright common if options liquidity allows; the thesis depends on a 2027 regulation-led adoption wave and SGI monetization, so defined-risk upside is the cleaner expression.
• Set a hard watch item on Q3: non-ADAS revenue as a share of total and SGI gross trajectory. If SGI stays de minimis after Q3 or actuation looks Sharpa-concentrated, reduce exposure because the 'full-stack platform' multiple will be harder to justify.
• If HSAI rallies hard on the call, fade part of the move into strength rather than adding; the market may be front-running a 2027 story that still needs several quarters of proof.
• For risk control, treat any price war headline in China lidar as a thesis breaker until proven otherwise; HSAI can defend better than most, but a broad discounting cycle would compress multiple expansion even if shipments keep growing.